The levels of ceramide in the placenta were found to be lower in T1D and T2D compared to the control group, which was associated with the increased expression of the enzyme that breaks down ceramide, acid ceramidase (ASAH1). Here, ASAH1 is linked to type 2 diabetes mellitus.